Factors associated with the use of sacubitril valsartan in patients with heart failure and reduced ejection fraction.

被引：0
|
作者：
Jorge Thierer, J. [1 ]
Ritondale, N. [2 ]
Palacio, M. S. [3 ]
Lobo Marquez, L. [4 ]
Aguilar, E. [5 ]
Soricetti, J. [6 ]
Ratto, R. [7 ]
Fernandez, D. [8 ]
Sanz, G. [8 ]
Echazarreta, D. [9 ]
Mazo, G. [10 ]
Bauk, L. [11 ]
Martin Napoli, M. [12 ]
Pereiro Gonzalez, S. M. [13 ]
Marino, J. [1 ]
机构：
[1] CEMIC, Buenos Aires, DF, Argentina
[2] Delta Sanat, Rosario, Argentina
[3] Clin Bazterr, Buenos Aires, DF, Argentina
[4] Inst Cardiol, San Miguel De Tucuman, Tucuman, Argentina
[5] Ctr Cardiovasc Clin Yunes, Santiago Del Estero, Argentina
[6] Hosp Durand, Buenos Aires, DF, Argentina
[7] Favaloro Fdn Univ Hosp, Buenos Aires, DF, Argentina
[8] Argentine Soc Cardiol SAC, Buenos Aires, DF, Argentina
[9] Hosp San Juan Dios, La Plata, Argentina
[10] Fdn Dr Jose Jalil, Catamarca, Argentina
[11] Sanatorio Cudad, Puerto Madryn, Argentina
[12] Austral Univ Hosp, Pilar, Argentina
[13] Hosp Ctr Churruca Visca, Buenos Aires, DF, Argentina
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1309
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [31] Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction
    Passino, Claudio
    Sciarrone, Paolo
    Vergaro, Giuseppe
    Borrelli, Chiara
    Spiesshoefer, Jens
    Gentile, Francesco
    Emdin, Michele
    Giannoni, Alberto
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 112 - 119
  • [32] Sacubitril/Valsartan Does Not Change the Use and Dose of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction
    Kido, Kazuhiko
    Bianco, Christopher
    Caccamo, Marco
    Hashiguchi, Masayuki
    Choo, Lyn Yuen
    Sokos, George
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (03) : 708 - 711
  • [33] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
  • [34] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Rex C. Liu
    American Journal of Cardiovascular Drugs, 2018, 18 : 473 - 482
  • [35] Left ventricular ejection fraction recovery in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan.
    Diez Villanueva, P.
    De la Cuerda, F.
    Vicent, L.
    Esteban-Fernandez, A.
    Gomez-Bueno, M.
    De Juan, J.
    Iniesta, A. M.
    Ayesta, A.
    Rojas, A.
    Bover, R.
    Iglesias, D.
    Garcia Aguado, M.
    Perea Egido, J. A.
    Salamanca, J.
    Martinez-Selles, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 206 - 207
  • [36] Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF)
    Nowak, Bernd
    Geiss, Ernst
    Boehm, Michael
    Weil, Joachim
    Boer, Jana
    KARDIOLOGIE, 2023, : 44 - 48
  • [37] Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction
    Raschi, Emanuel
    Diemberger, Igor
    Sabatino, Mario
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Potena, Luciano
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) : 303 - 320
  • [38] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Khan, Muhammad Nauman
    Soomro, Najia Aslam
    Naseeb, Khalid
    Bhatti, Usman Hanif
    Rauf, Rubina
    Balouch, Iram Jehan
    Moazzam, Ali
    Bashir, Sonia
    Ashraf, Tariq
    Karim, Musa
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [39] Sacubitril/valsartan reduces ventrucular arrhythmias in heart failure with reduced ejection fraction
    Lamaida, Norman
    Torella, Giorgio
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N26 - N26
  • [40] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
12345